Award of sylvatica's DHA sbir phase II enhancement medical r & d contract for "development of a novel cryostasis cocktail and protocol for high subzero banking of human organs"
Ended Definitive Contract Awarded Last action
- Contract number
- W81XWH21C0060
- Awardee
-
Sylvatica Biotech Inc. UEI FJJVUJGDDLS3
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $549,604
Award facts
- Opportunity
-
- HQ003415R1DSB Solicitation number
- Contract value 100% obligated
- $549,604.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- North Charleston, SC 29405, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $549,604 |
About this award
Sylvatica Biotech Inc. has been awarded a $549,604 firm fixed price contract by the Department of the Army Medical Command to further develop a novel cryostasis cocktail and protocol for high subzero banking of human organs under the Small Business Innovation Research Program Phase II Enhancement. The research will build upon Sylvatica's prior Phase I SBIR work to advance organ cryopreservation technology. The total small business set aside contract will be performed in Charleston, South Carolina through June 2023. The award provides continued support for Sylvatica's efforts to establish protocols and solutions aimed at extending organ viability for transplantation through ultra-low temperature storage.
Quick answers
Who was awarded contract W81XWH21C0060?
W81XWH21C0060 was awarded to Sylvatica Biotech Inc. by Medical Command (Department of the Army) on May 3, 2021.
How much is contract W81XWH21C0060 worth?
The government has obligated $549,604 on W81XWH21C0060.
Was contract W81XWH21C0060 competed?
The extent of competition for W81XWH21C0060 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award